: , * .. 1 , .. 2 , .. 3 50 % , 14 60 %. , , . ( - - ), , . - , , , . - . , - . , 2010-2020 , . (22480 ), (n = 146). - (29207 ) . , , , . () (., 2000). Escherichia coli. 4.2.1890-04. - (10 ), (30 ), (30 ), (30 ), (10 ), (10 ), (30 ), (30 ), (10 ), (5 ), (5 ) (5 ), (30 ), (30 ). (2020-2021 ) E. coli, - (STEC), . (n = 61) . - (stx1 stx2) . , 2010-2020 : 20 %. . , , . , . -8, 15, 20, 101, 115, E. coli 157. -
No takes yet. Share an insight, caveat, or question.
I.N. Zhdanova (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: